Both IFNG and IL2 mRNA were increased in the peripheral blood mononuclear cells (PBMCs) of GvHD patients that received a donor lymphocyte infusion for the treatment of relapsed leukemia after allogeneic HSCT and IL2 mRNA expression correlated with the progression of GvHD (121). The gene discussed is IL2; the disease is leukemia.